Tetrapyrrole photosensitisers, determinants of subcellular localisation and mechanisms of photodynamic processes in therapeutic approaches

Expert Opinion on Therapeutic Patents

Volumn 18, Issue 9, 2008, Pages 1011-1025

  Bonneau, Stéphanie ^a   Vever Bizet, Christine ^a  

^a SORBONNE UNIVERSITÉ   (France)

Author keywords

Kinecics; Low density lipoproteins; Photochemical internalisation (PCI); Photodynamic therapy (PDT); Targeting; Tetrapyrrole photosensitisers

Indexed keywords

DEUTEROPORPHYRIN IX; DISULFONATED ALUMINUM PHTHALOCYANINE; LOW DENSITY LIPOPROTEIN; PALLADIUM BACTERIOPHEOPHORBIDE; PHOTOFRIN; PHOTOSENSITIZING AGENT; PHTHALOCYANINE DERIVATIVE; TALAPORFIN; TEMOPORFIN; TETRAPYRROLE DERIVATIVE; UNCLASSIFIED DRUG; VERTEPORFIN;

APOPTOSIS; CANCER DIAGNOSIS; CANCER THERAPY; CELL DEATH; CELL MEMBRANE; CELL MEMBRANE TRANSPORT; CELLULAR DISTRIBUTION; DIAGNOSTIC VALUE; DRUG DISTRIBUTION; DRUG HALF LIFE; DRUG MECHANISM; DRUG SELECTIVITY; DRUG STRUCTURE; FLUORESCENCE ANALYSIS; FLUORESCENCE MICROSCOPY; HUMAN; LIGHT; LIGHT ABSORPTION; LYSOSOME; MITOCHONDRIAL MEMBRANE POTENTIAL; NEOPLASM; NONHUMAN; PHOTOCHEMICAL INTERNALIZATION; PHOTODYNAMIC THERAPY; PHYSICAL CHEMISTRY; REVIEW; SIDE EFFECT; SKIN SENSITIVITY; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS; TREATMENT RESPONSE; TUMOR CELL DESTRUCTION;

EID: 52649126309     PISSN: 13543776     EISSN: None     Source Type: Journal    
DOI: 10.1517/13543776.18.9.1011     Document Type: Review

References (157)

1. Spikes JD. Photodynamic reactions in photomedicine. In: Regan JD, Parrish JA, editors, The science of photomedicine. New York: Plenum Press; 1982. p. 113-44
2. Dougherty TJ, Gomer CJ, Henderson BW, et al. Photodynamic therapy. J Natl Cancer Inst 1998;90(12):889-905
3. Allergan, Inc. Photodynamic therapy for pre-melanomas. WO3077911; 2003
4. QLT, Inc.; Rubinchik V, Visser MD. Photodynamic therapy for the treatment of prostatic conditions. WO2005077457; 2005
5. The Trustees of the University of Pennsylvania. Photodynamic therapy-generated mesothelioma vaccine. WO2007133728; 2007
6. Photodynamic therapy with verteporfin for age-related macular degeneration. American Academy of Ophthalmology. Ophthalmology 2000;107(12):2314-7
7. QLT Inc., Novartis AG; Strong HA, Ali MA, Reaves TA Jr. Method to prevent vision loss. WO02062385; 2002
8. Massachusetts Eye, Ear Infirmary; Poulaki V, Miller JW, Gragoudas ES. Methods and compositions for treating conditions of the eye. WO2007097839; 2007
9. Dolmans DE, Fukumura D, Jain RK. Photodynamic therapy for cancer. Nat Rev Cancer 2003;3(5):380-7
10. Moan J, Pettersen EO, Christensen T. The mechanism of photodynamic inactivation of human cells in vitro in the presence of haematoporphyrin. Br J Cancer 1979;39(4):398-407
11. Niedre MJ, Secord AJ, Patterson MS, Wilson BC. In vitro tests of the validity of singlet oxygen luminescence measurements as a dose metric in photodynamic therapy. Cancer Res 2003;63(22):7986-94
12. Health Research, Inc. New photosensitizing agents. WO9000895; 1990
13. Figge FH, Barnett DJ. Anatomic evaluation of a jet injection instrument designed to minimize pain and inconvenience of parenteral therapy. Am Pract Dig Treat 1948;3(4):197-206
14. Moan J, Peng Q. An outline of the history of PDT. In: Patrice T, editor, Phorodynamic therapy. RSC; 2003. p. 1-17
15. Dougherty TJ. Activated dyes as antitumor agents. J Natl Cancer Inst 1974;52(4):1333-6
16. Dougherty TJ, Kaufman JE, Goldfarb A, et al. Photoradiation therapy for the treatment of malignant tumors. Cancer Res 1978;38(8):2628-35
17. Dougherty TJ, Lawrence G, Kaufman JH, et al. Photoradiation in the treatment of recurrent breast carcinoma. J Natl Cancer Inst 1979;62(2):231-7
18. Health Research, Inc. In situ photodynamic therapy. US5257970; 1993
19. Lipson RL, Baldes EJ. The photodynamic properties of a particular hematoporphyrin derivative. Arch Dermatol 1960;82:508-16
20. Oncology Research & Development, Inc. Purified hematoporphyrin derivative for diagnosis and treatment of tumors and method. WO8401382; 1984
21. Wayne State University. Hematoporphyrin derivative and method of preparation and purification. US4861876; 1989
22. Health Research, Inc. Purified hematoporphyrin dimers and trimers useful in photodynamic therapy. US5190966; 1993
23. Baas P, van Mansom I, van Tinteren H, et al. Effect of N-acetylcysteine on Photofrin-induced skin photosensitivity in patients. Lasers Surg Med 1995;16(4):359-67
24. Orenstein A, Kostenich G, Roitman L, et al. A comparative study of tissue distribution and photodynamic therapy selectivity of chlorin e6, photofrin II and ALA-induced protoporphyrin IX in a colon carcinoma model. Br J Cancer 1996;73(8):937-44
25. Hahn SM, Putt ME, Metz J, et al. Photofrin uptake in the tumor and normal tissues of patients receiving intraperitoneal photodynamic therapy. Clin Cancer Res 2006;12(18):5464-70
26. Kessel D, Thompson P. Purification and analysis of hematoporphyrin and hematoporphyrin derivative by gel exclusion and reverse-phase chromatography. Photochem Photobiol 1987;46(6):1023-5
27. Mojzisova H, Bonneau S, Brault D. Structural and physico-chemical determinants of the interactions of macrocyclic photosensitizers with cells. Eur Biophys J 2007;36(8):943-53
28. Boyle RW, Dolphin D. Structure and biodistribution relationships of photodynamic sensitizers. Photochem Photobiol 1996;64(3):469-85
29. Ackroyd R, Kelty C, Brown N, Reed M. The history of photodetection and photodynamic therapy. Photochem Photobiol 2001;74(5):656-69
30. The University of British Columbia. Hydro-monobenzoporphyrin wavelength-specific cytotoxic agents. US4920143; 1990
31. The University of British Columbia. Benzoporphyrin derivatives for photodynamic. US5214036; 1993
32. The Liposome Company, Inc. Benzoporphyrin vesicles and their use in photodynamic therapy. US5389378; 1995
33. The University of British Columbia. Photoactive benzoporphyrin derivatives. EP1380586; 2004
34. Richter AM, Jain AK, Canaan AJ, et al. Photosensitizing efficiency of two regioisomers of the benzoporphyrin derivative monoacid ring A (BPD-MA). Biochem Pharmacol 1992;43(11):2349-58
35. The University of British Columbia, Macalpine J, Dolphin D. Improved beta, beta,-dihydroxy meso-substituted chlorins, isobacteriochlorins, and bacteriochlorins. WO0061584; 2000
36. Ceramoptec Industries, Inc. Water-soluble porphyrin derivatives for photodynamic therapy, their use and manufacture. US2003023081; 2003
37. Health Research, Inc. Water soluble tetrapyrollic photosensitizers for photodynamic therapy. US2007149497; 2007
38. Bannett R, White RD, Winfield UJ, Berenbaum MC. Hydroporphyrins of the meso-tetra(hydroxyphenyl)porphyrin series as tumour photosensitizers. Biochem J 1989;261(1):277-80
39. Hamari Yakuhin Kogyo Kabushiki Kaisha (Hamari Chemicals Ltd). Pheophorbide derivatives. EP0322198; 1989
40. Health Research, Inc. Photosensitizing agents. US5002962; 1991
41. Health Research, Inc. Pyropheophorbides and their use inphotodynamic therapy. EP1146046; 2001
42. Koudinova NV, Pinthus JH, Brandis A, et al. Photodynamic therapy with Pd-Bacteriopheophorbide (TOOKAD): successful in vivo treatment of human prostatic small cell carcinoma xenografts. Int J Cancer 2003;104(6):782-9
43. University Hospitals of Cleveland. Novel methods of syntheses of phthalocyanine compounds. WO9814521; 1998
44. Photopharmica Limited. Photosensitisers. WO0224226; 2002
45. Board of Supervisors of Louisiana State University and Agricultural and Mechanical College, Hammer R, Soper SA. Tetrazaporphyrin-based compounds and their uses. WO2007009101; 2007
46. Laptev VP, Petrov VV, Andreev SM, et al. Pharmaceutical composition for photodynamic therapy and a method for treating oncological diseases by using said composition. WO2007075119; 2007
47. Bonnett R. Photosensitizers of the porphyrin and phthalocyanine series for photodynamic therapy. Chem Soc Rev 1995;24:19-33
48. Brasseur N, Ali H, Langlois R, van Lier JE. Biological activities of phthalocyanines - IX. Photosensitization of V-79 Chinese hamster cells and EMT-6 mouse mammary tumor by selectively sulfonated zinc phthalocyanines. Photochem Photobiol 1988;47(5):705-11
49. Reddi E, Zhou C, Biolo R, et al. Liposome- or LDL-administered Zn (II)-phthalocyanine as a photodynamic agent for tumours. I. Pharmacokinetic properties and phototherapeutic efficiency. Br J Cancer 1990;61(3):407-11
50. Kennedy JC, Pottier RH, Pross DC. Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. J Photochem Photobiol B 1990;6(1-2):143-8
51. Pass HI. Photodynamic therapy in oncology: mechanisms and clinical use. J Natl Cancer Inst 1993;85:443-56
52. Barbieri L, Battelli MG, Stirpe F. Ribosome-inactivating proteins from plants. Biochim Biophys Acta 1993;1154(3-4):237-82
53. Zabner J, Fasbender AJ, Moninger T, et al. Cellular and molecular barriers to gene transfer by a cationic lipid. J Biol Chem 1995;270(32):18997-9007
54. Wu M. Enhancement of immunotoxin activity using chemical and biological reagents. Br J Cancer 1997;75(9):1347-55
55. Berg K, Selbo PK, Prasmickaite L, et al. Photochemical internalization: a novel technology for delivery of macromolecules into cytosol. Cancer Res 1999;59(6):1180-3
56. The Norwegian Radium Hospital Research Foundation; Jones E, Berg K, Prasmickaite L, et al. Photochemical internalization for delivery of molecules into the cytosol. WO0244396; 2002
57. Berg K, Prasmickaite L, Selbo PK, et al. Photochemical internalization (PCI) - a novel technology for release of macromolecules from endocytic vesicles. Oftalmologia 2003;56(1):67-71
58. Photocure AS. Transfer of molecules into the cytosol of cells US2003134813; 2003
59. Berg K, Folini M, Prasmickaite L, et al. Photochemical internalization: a new tool for drug delivery. Curr Pharm Biotechnol 2007;8(6):362-72
60. Selbo PK, Sivam G, Fortstad O, et al. In vivo documentation of photochemical internalization, a novel approach to site specific cancer therapy. Int J Cancer 2001;92(5):761-6
61. Dietze A, Boosted A, Hogset A, Berg K. Photochemical internalization enhances the cytotoxic effect of the protein toxin gelonin and transgene expression in sarcoma cells. Photochem Photobiol 2003;78(3):283-9
62. Dietze A, Peng Q, Selbo PK, et al. Enhanced photodynamic destruction of a transplantable fibrosarcoma using photochemical internalisation of gelonin. Br J Cancer 2005;92(11):2004-9
63. Hamamatsu Photonics KK. Method of photodynamic diagnosis for vascular diseases. EP1847267; 2007
64. Kodesh SA, Eren D, Mazor N. Tetraarylporphine derivatives and uses thereof WO2008018063; 2008
65. Yeda Research and Development Co. Ltd.; Scherz A, et al. Conjugates of RGD peptides and porphyrin or (bacterio) chlorophyll photosynthesizers and their uses. WO2008023378; 2008
66. Zimmermann A, Ritsch-Marte M, Kostron H. mTHPC-mediated photodynamic diagnosis of malignant brain tumors. Photochem Photobiol 2001;74(4):611-6
67. Solban N, Rizvi I, Hasan T. Targeted photodynamic therapy. Lasers Surg Med 2006;38(5):522-31
68. Fritsch C, Ruzicka T. Fluorescence diagnosis and photodynamic therapy in dermatology from experimental state to clinic standard methods. J Environ Pathol Toxicol Oncol 2006;25(1-2):425-39
69. Malik E, Berg C, Meyhofer-Malik A, et al. Fluorescence diagnosis of endometriosis using 5-aminolevulinic acid. Surg Endosc 2000;14(5):452-5
70. Bourg-Heckly G, Blais J, Padilla JJ, et al. Endoscopic ultraviolet-induced autofluorescence spectroscopy of the esophagus: tissue characterization and potential for early cancer diagnosis. Endoscopy 2000;32(10):756-65
71. Bellnier DA, Dougherty TJ. A preliminary pharmacokinetic study of intravenous Photofrin in patients. J Clin Laser Med Surg 1996;14(5):311-4
72. Jones HJ, Vernon DI, Brown SB. Photodynamic therapy effect of m-THPC (Foscan) in vivo: correlation with pharmacokinetics. Br J Cancer 2003;89(2):398-404
73. Brun PH, DeGroot JL, Dickson EF, et al. Determination of the in vivo pharmacokinetics of palladium-bacteriopheophorbide (WST09) in EMT6 tumour-bearing Balb/c mice using graphite furnace atomic absorption spectroscopy. Photochem Photobiol Sci 2004;3(11-12):1006-10
74. Bellnier DA, Ho YK, Pandey RK, et al. Distribution and elimination of photofrin II in mice. Photochem Photobiol 1989;50(2):221-8
75. Chan WS, Marshall JF, Svensen R, et al. Effect of sulfonation on the cell and tissue distribution of the photosensitizer aluminum phthalocyanine. Cancer Res 1990;50(15):4533-8
76. Hamblin MR, Newman EL. On the mechanism of the tumour-localising effect in photodynamic therapy. J Photochem Photobiol B 1994;23(1):3-8
77. Steba Biotech NV; Brun PH, Prudhomme A, Barnoux J-L. Injectable galenic formulation for use in a diagnosis or a photodynamic therapy and method for preparing same. EP1406616; 2004
78. Chowdhary RK, Dolphin D. Drug delivery systems for photodynamic therapy. US2007086973; 2007
79. Woodburn K, Chang CK, Lee S, et al. Biodistribution and PDT efficacy of a ketochlorin photosensitizer as a function of the delivery vehicle. Photochem Photobiol 1994;60(2):154-9
80. Cunderlikova B, Kongshaug M, Gangeskar L, Moan J. Increased binding of chlorin e6; to lipoproteins at low PH values. Int J Biochem Cell Biol 2000;32(7):759-68
81. Mojzisova H, Bonneau S, Vever-Bizer C, Brault D. The pH-dependent distribution of the photosensitizer chlorin e6 among plasma proteins and membranes: a physico-chemical approach. Biochim Biophys Acta 2007;1768(2):366-74
82. Gullino PM, Grantham FH, Smith SH, Haggerty AC. Modifications of the acid-base status of the internal milieu of tumors. J Natl Cancer Inst 1965;34(6):857-69
83. Tannock IF, Rotin D. Acid PH in tumors and its potential for therapeutic exploitation. Cancer Res 1989;49(16):4373-84
84. Gal D, Chashi M, MacDonald PC, et al. Low-density lipoprotein as a potential vehicle for chemotherapeutic agents and radionucleotides in the management of gynecologic neoplasms. Am J Obstet Gynecol 1981;139(8):877-85
85. Vitols S, Peterson C, Larsson O, et al. Elevated uptake of low density lipoproteins by human lung cancer tissue in vivo. Cancer Res 1992;52(22):6244-7
86. Jori G, Beltramini M, Reddi E, et al. Evidence for a major role of plasma lipoproteins as hematoporphyrin carriers in vivo. Cancer Lett 1984;24(3):291-7
87. Bonneau S, Morliere P, Brault D. Dynamics of interactions of photosensitizers with lipoproteins and membrane-models: correlation with cellular incorporation and subcellular distribution. Biochem Pharmacol 2004;68(7):1443-52
88. Silva JN, Filipe P, Morliere P, et al. Photodynamic therapies: principles and present medical applications. Biomed Mater Eng 2006;16(4 Suppl):S147-54
89. Mojzisova H, Bonneau S, Vever-Bizet C, Brault D. Cellular uptake and subcellular distribution of chlorin e6 as functions of PH and interactions with membranes and lipoproteins. Biochim Biophys Acta 2007;1768(11):2748-56
90. Bonneau S, Vever-Bizet C, Mojzisova H, Brault D. Tetrapyrrole-photosensitizers vectorization and plasma LDL: a physico-chemical approach. Int J Pharm 2007;344(1-2):78-87
91. Thomas JP, Girotti AW. Glucose administration augments in vivo uptake and phototoxicity of the tumor-localizing fraction of hematoporphyrin derivative. Photochem Photobiol 1989;49(3):241-7
92. Cunderlikova B, Gangeskar L, Moan J. Acid-base properties of chlorin e6: relation to cellular uptake. J Photochem Photobiol B 1999;53(1-3):81-90
93. Bonneau S, Maman N, Brault D. Dynamics of pH-dependent self-association and membrane binding of a dicarboxylic porphyrin: a study with small unilamellar vesicles. Biochim Biophys Acta 2004;1661(1):87-96
94. Henderson BW, Bellnier DA, Greco WR, et al. An in vivo quantitative structure-activity relationship for a congeneric series of pyropheophorbide derivatives as photosensitizers for photodynamic therapy. Cancer Res 1997;57(18):4000-7
95. Castano AP, Demidova TN, Hamblin MR. Mechanisms in photodynamic therapy: part two - cellular signaling, cell metabolism and modes of cell death. Photodiagn Photodyn Ther 2005;2:1-23
96. Henderson BW, Waldow SM, Mang TS, et al. Tumor destruction and kinetics of tumor cell death in two experimental mouse tumors following photodynamic therapy. Cancer Res 1985;45(2):572-6
97. Korbelik M, Krosl G. Cellular levels of photosensitisers in tumours: the role of proximity to the blood supply. Br J Cancer 1994;70(4):604-10
98. Gomer CJ, Razum NJ. Acute skin response in albino mice following porphyrin photosensitization under oxic and anoxic conditions. Photochem Photobiol 1984;40(4):435-9
99. Marchal S, Fadloun A, Maugain E, et al. Necrotic and apoptotic features of cell death in response to Foscan photosensitization of HT29 monolayer and multicell spheroids. Biochem Pharmacol 2005;69(8):1167-76
100. Henderson BW, Busch TM, Vaughan LA, et al. Photofrin photodynamic therapy can significantly deplete or preserve oxygenation in human basal cell carcinomas during treatment, depending on fluence rate. Cancer Res 2000;60(3):525-9
101. Dolmans DE, Kadambi A, Hill JS, et al. Targeting tumor vasculature and cancer cells in orthotopic breast tumor by fractionated photosensitizer dosing photodynamic therapy. Cancer Res 2002;62(15):4289-94
102. Abels C. Targeting of the vascular system of solid tumours by photodynamic therapy (PDT). Photochem Photobiol Sci 2004;3(8):765-71
103. Henderson BW, Fingar VH. Relationship of tumor hypoxia and response to photodynamic treatment in an experimental mouse tumor. Cancer Res 1987;47(12):3110-4
104. Korbelik M, Krosl G, Krosl J, Dougherty GJ. The role of host lymphoid populations in the response of mouse EMT6 tumor to photodynamic therapy. Cancer Res 1996;56(24):5647-52
105. Krosl G, Korbelik M, Dougherty GJ. Induction of immune cell infiltration into murine SCCVII tumour by photofrin-based photodynamic therapy. Br J Cancer 1995;71(3):549-55
106. Gollnick SO, Vaughan L, Henderson BW. Generation of effective antitumor vaccines using photodynamic therapy. Cancer Res 2002;62(6):1604-8
107. Xue LY, Chiu SM, Azizuddin K, et al. Protection by Bcl-2 against apoprotic but not autophagic cell death after photodynamic therapy. Autophagy 2008;4(1):125-7
108. Kessel D, Reiners JJ Jr. Apoptosis and autophagy after mitochondrial or endoplasmic reticulum photodamage. Photochem Photobiol 2007;83(5):1024-8
109. Kessel D, Vicente MG, Reiners JJ Jr. Initiation of apoptosis and autophagy by photodynamic therapy. Lasers Surg Med 2006;38(5):482-8
110. Kessel D, Vicente MG, Reiners JJ Jr. Initiation of apoptosis and autophagy by photodynamic therapy. Autophagy 2006;2(4):289-90
111. Kessel D, Reiners JJ Jr. Initiation of apoptosis and autophagy by the Bcl-2 antagonist HA14-1. Cancer Lett 2007;249(2):294-9
112. Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer 1972;26(4):239-57
113. Dougherty TJ. Photodynamic therapy. Adv Exp Med Biol 1985;193:313-28
114. Dellinger M. Apoptosis or necrosis following Photofrin photosensitization: influence of the incubation protocol. Photochem Photobiol 1996;64(1):182-7
115. Kessel D, Luo Y. Mitochondrial photodamage and PDT-induced apoprosis. J Photochem Photobiol B 1998;42(2):89-95
116. Kessel D, Luo Y. Intracellular sites of photodamage as a factor in apoptotic cell death. J Porphyr Phthalocyan 2001;5:181-4
117. Plaetzer K, Kiesslich T, Krammer B, Hammerl P. Characterization of the cell death modes and the associated changes in cellular energy supply in response to AlPcS4-PDT. Photochem Photobiol Sci 2002;1(3):172-7
118. Agarwal ML, Clay ME, Harvey EJ, et al. Photodynamic therapy induces rapid cell death by apoprosis in L5178Y mouse lymphoma cells. Cancer Res 1991;51(21):5993-6
119. Dahle J, Kaalhus O, Moan J, Steen HB. Cooperative effects of photodynamic treatment of cells in microcolonies. Proc Natl Acad Sci USA 1997;94(5):1773-8
120. Shao C, Furusawa Y, Kobayashi Y, et al. Bystander effect induced by counted high-LET particles in confluent human fibroblasts: a mechanistic study. FASEB J 2003;17(11):1422-7
121. Dummin H, Cernay T, Zimmermann HW. Selective photosensitization of mitochondria in HeLa cells by cationic Zn (II) phthalocyanines with lipophilic side-chains. J Photochem Photobiol B 1997;37(3):219-29
122. Morgan J, Potter WR, Oseroff AR. Comparison of photodynamic targets in a carcinoma cell line and its mitochondrial DNA-deficient derivative. Photochem Photobiol 2000;71(6):747-57
123. Salet C, Moreno G. Photodynamic effects of haematoporphyrin on respiration and calcium uptake in isolated mitochondria. Int J Radiat Biol Relat Stud Phys Chem Med 1981;39(2):227-30
124. Salet C, Moreno G. Photosensitization of mitochondria. Molecular and cellular aspects. J Photochem Photobiol B 1990;5(2):133-50
125. Atlante A, Passarella S, Quagliariello E, et al. Haematoporphyrin derivative (Photofrin II) photosensitization of isolated mitochondria: inhibition of ADP/ATP translocator. J Photochem Photobiol B 1989;4(1):35-46
126. Saler C, Moreno G, Ricchelli F, Bernardi P. Singlet oxygen produced by photodynamic action causes inactivation of the mitochondrial permeability transition pore. J Biol Chem 1997;272(35):21938-43
127. Oleinick NL, Morris RL, Belichenko I. The role of apoprosis in response to photodynamic therapy: what, where, why, and how. Photochem Photobiol Sci 2002;1(1):1-21
128. Berg K, Moan J. Lysosomes as photochemical targets. Int J Cancer 1994;59(6):814-22
129. Stoka V, Turk B, Schendel SL, et al. Lysosomal protease pathways to apoptosis. Cleavage of bid, not pro-caspases, is the most likely route. J Biol Chem 2001;276(5):3149-57
130. Kessel D, Luo Y, Deng Y, Chang CK. The role of subcellular localization in initiation of apoptosis by photodynamic therapy. Photochem Photobiol 1997;65(3):422-6
131. Kessel D, Poretz RD. Sites of photodamage induced by photodynamic therapy wich a chlorin e6 triacetoxymethyl ester (CAME). Photochem Photobiol 2000;71(1):94-6
132. Lavie G, Kaplinsky C, Toren A, et al. A photodynamic pathway to apoptosis and necrosis induced by dimethyl tetrahydroxyhelianthrone and hypericin in leukaemic cells: possible relevance to photodynamic therapy. Br J Cancer 1999;79(3-4):423-32
133. Luo Y, Kessel D. Initiation of apoptosis versus necrosis by phorodynamic therapy with chloroaluminum phthalocyanine. Photochem Photobiol 1997;66(4):479-83
134. Ruck A, Kollner T, Dietrich A, et al. Fluorescence formation during photodynamic therapy in the nucleus of cells incubated with cationic and anionic water-soluble photosensitizers. J Photochem Photobiol B 1992;12(4):403-12
135. Wood SR, Holroyd JA, Brown SB. The subcellular localization of Zn(II) phthalocyanines and their redistribution on exposure to light. Photochem Photobiol 1997;65(3):397-402
136. Teiten MH, Bezdetnaya L, Morliere P, et al. Endoplasmic reticulum and Golgi apparatus are the preferential sites of Foscan localisation in cultured tumour cells. Br J Cancer 2003;88(1):146-52
137. Chen JY, Mak NK, Yow CM, et al. The binding characteristics and intracellular localization of temoporfin (mTHPC) in myeloid leukemia cells: phototoxicity and mitochondrial damage. Photochem Phocobiol 2000;72(4):541-7
138. Matroule JY, Hellin AC, Morliere P, et al. Role of nuclear factor-kappa B in colon cancer cell apoptosis mediated by aminopyropheophorbide photosensitization. Photochem Photobiol 1999;70(4):540-8
139. Kessel D. In vitro photosensitization with a benzoporphyrin derivative. Phorochem Photobiol 1989;49(5):579-82
140. Sailer R, Strauss WS, Emmert H, et al. Plasma membrane associated location of sulfonated meso-tetraphenylporphyrins of different hydrophilicity probed by total internal reflection fluorescence spectroscopy. Photochem Photobiol 2000;71(4):460-5
141. Berg K, Western A, Bommer JC, Moan J. Intracellular localization of sulfonated meso-tetraphenylporphines in a human carcinoma cell line. Photochem Photobiol 1990;52(3):481-7
142. MacDonald IJ, Morgan J, Bellnier DA, et al. Subcellular localization patterns and their relationship to photodynamic activity of pytopheophorbide-a derivatives. Photochem Photobiol 1999;70(5):789-97
143. Kessel D, Luguya R, Vicente MG. Localization and photodynamic efficacy of two cationic porphyrins varying in charge distributions. Photochem Photobiol 2003;78(5):431-5
144. Krasnovsky AA Jr, Neverov KV, Egorov S, et al. Photophysical studies of pheophorbide a and pheophytin a. Phosphorescence and photosensitized singlet oxygen luminescence. J Photochem Photobiol B 1990;5(2):245-54
145. Kelbauskas L, Dietei W. Internalization of aggregated photosensitizers by tumor cells: subcellular time-resolved fluorescence spectroscopy on derivatives of pyropheophorbide-a ethers and chlorin e6 under femtosecond one- and two-photon excitations. Photochem Photobiol 2002;76(6):686-94
146. Jori G, Reddi E, Cozzani I, Tomio L. Controlled targeting of different subcellular sites by porphyrins in tumour-bearing mice. Br J Cancer 1986;53(5):615-21
147. Candide C, Morliere P, Maziere JC, et al. In vitro interaction of the photoactive anticancer porphyrin derivative photofrin II with low density lipoprotein, and its delivery to cultured human fibroblasts. FEBS Lett 1986;207(1):133-8
148. Stein WD. Permeability for lipophilic molecules. Membrane transport: Elsevier; 1981. p. 1-128
149. Kepczynski M, Pandian RP, Smith KM, Ehrenberg B. Do liposome-binding constants of porphyrins correlate with their measured and predicted partitioning between octanol and water? Photochem Photobiol 2002;76(2):127-34
150. Vever-Bizet C, Brault D. Kinetics of incorporation of porphyrins into small unilamellar vesicles. Biochim Biophys Acta 1993;1153(2):170-4
151. Kuzelova K, Brault D. Kinetic and equilibrium studies of porphyrin interactions with unilamellar lipidic vesicles. Biochemistry 1994;33(32):9447-59
152. Maman N, Dhami S, Phillips D, Brault D. Kinetic and equilibrium studies of incorporation of di-sulfonated aluminum phthalocyanine into unilamellar vesicles. Biochim Biophys Acta 1999;1420(1-2):168-78
153. Brault D, Vever-Bizet C, Le Doan T. Spectrofluorimetric study of porphyrin incorporation into membrane models - evidence for PH effects. Biochim Biophys Acta 1986;857(2):238-50
154. Kuzelova K, Brault D. Interactions of dicarboxylic porphyrins with unilamellar lipidic vesicles: drastic effects of pH and cholesterol on kinetics. Biochemistry 1995;34(35):11245-55
155. Bonneau S, Vever-Bizet C, Morliere P, et al. Equilibrium and kinetic studies of the interactions of a porphyrin with low-density lipoproteins. Biophys J 2002;83(6):3470-81
156. Wessels JM, Strauss W, Seidlitz HK, et al. Intracellular localization of meso-tetraphenylporphine tetrasulphonate probed by time-resolved and microscopic fluorescence spectroscopy. J Photochem Photobiol B 1992;12(3):275-84
157. Moan J, Berg K, Anholt H, Madslien K. Sulfonated aluminium phthalocyanines as sensitizers for photochemotherapy. Effects of small light doses on localization, dye fluorescence and photosensitivity in V79 cells. Int J Cancer 1994;58(6):865-70